Blaustein Robert 4
4 · Edgewise Therapeutics, Inc. · Filed Aug 14, 2025
Insider Transaction Report
Form 4
Blaustein Robert
Chief Development Officer
Transactions
- Award
Restricted Stock Units
2025-08-12+17,500→ 17,500 totalExercise: $0.00Exp: 2035-08-12→ Common Stock (17,500 underlying) - Award
Stock Options (Right to buy)
2025-08-12+105,000→ 105,000 totalExercise: $13.39Exp: 2035-08-12→ Common Stock (105,000 underlying)
Footnotes (2)
- [F1]Restricted Stock Units ("RSUs") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2026.
- [F2]1/48th of the shares subject to the option vest each month beginning on September 12, 2025, subject to the Reporting Person continuing as a service provider through each vest date.